|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 14, 2021 )
Market Overview
Coagulation tests assess blood’s ability to clot as well as the time it takes to clot. Testing can assist a doctor in determining the risk of excessive bleeding or the formation of clots (thrombosis) in blood vessels.
View full report: https://bit.ly/3j0zZ2N
Market Dynamics
The factors driving the global coagulation monitoring products market are the increasing demand for point of care testing devices. In addition, increasing technological advancements in monitoring devices are also expected to drive market growth over the forecast period.
Increasing point of care testing devices is expected to drive the global coagulation monitoring products market
The rapid, specific examination of bodily fluids at the bedside is known as point-of-care testing (POCT). There is an ever-expanding range of POCT available, the majority of which are beyond the scope of this article, which will focus on those that are routinely used and important to the management of perioperative coagulation.
Because typical laboratory tests have a somewhat long turnaround time. There is growing interest in point-of-care coagulation testing (POCCT) to avoid unnecessary transfusion, which can offer results in minutes. Furthermore, the widespread acceptance of the current cell-based coagulation model has resulted in a focus on the critical role of platelets and a particular interest in devices that test whole blood rather than plasma, which is employed in laboratory-based tests.
The prothrombin time (PT) and activated partial thromboplastin time (aPTT), which provide information on the first phase of coagulation up to fibrin production, are examples of the latter. Viscoelastic POCCT devices, on the other hand, produce information on all phases of coagulation, offering insight into interactions between the cellular and plasma components of whole blood and the fibrinolytic system's activity which are critical for successful hemostasis.
The most recent POC coagulation analyzers produce real-time results while maintaining the central lab's diagnostic quality controls. POC testing must strike a compromise between the desire for quick findings and the absolute requirement for accuracy and QC that the lab guarantees.
Siemens Healthineers' Xprecia Stride Coagulation Analyzer is a recent FDA-cleared POC PT/INR gadget. This device has established performance parity in PT/INR testing with the Roche CoaguChek XS POC system and reference laboratory analysis. Recent point-of-care PT/INR systems include both electronic and internal QC checks on test strips. Convenient device test strip ejects mechanisms allow for the safe disposal of spent strips, reducing odors.
Market Segmentation
By Product
• Assays
• Reagents
By End-User
• Hospitals
• Clinics and Diagnostic centers
• Home Setting
• Ambulatory Settings
Download free sample: https://bit.ly/3azU5MG
Geographical Analysis
North America region accounted for the largest market share in the global coagulation monitoring products market
With the growing incidence of bleeding disorders and increasing approvals, this region is expected to dominate the global coagulation monitoring products market.
In the United States, one in every 5,000 male births is affected by hemophilia A, and around 400 babies are born with hemophilia each year. Haemophilia affects 400 thousand people worldwide, with around 20,000 affected in the United States. According to CDC, the exact number of hemophilia patients in the United States is unknown.
According to a new study that analyzed data collected on patients receiving care in federally sponsored hemophilia treatment centers from 2012 to 2018, up to 33,000 boys in the United States have the illness. As of 2019, 18,008 persons were diagnosed with hemophilia, a genetic blood condition that impairs normal blood clotting and coagulation.
The US Food and Drug Administration (FDA) authorized manufacturers to adapt coagulation systems for assessing whole blood viscoelastic characteristics, allowing for increased use in hospitals for supportive care of COVID-19 patients. The enforcement policy, published in January 2021, is only temporary and will be in effect only during the COVID-19 public health emergency.
Competitive Landscape
The global coagulation monitoring products market is highly competitive with the increasing demand during COVID-19 and technological advancement in products.
Major key players in the global coagulation monitoring products market are CoaguSense Inc., Helena Laboratories, Hemosonics, Siemens, Thermo Fisher Scientific, HORIBA Medical, Maccura Biotechnology Co., Sclavo Diagnostics International S.r.l, Biosystems S. and Bio Group Medical System.
Related Topic's
Cardiometabolic Monitoring Products Market, Wearable Fitness Devices Market, Wearable Medical Devices Market, Remote Patient Monitoring Market, Multiparameter Patient Monitoring Devices Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
